Skin Cancer
Show only recruiting trials?

COMBI-APlus | CDRB436F2410
Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes (COMBI-APlus)
Status
Closed to Accrual
JCP
JCP051
NCT
NCT03551626

CheckMate 238
Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma (CheckMate 238)
Status
Closed to Accrual
JCP
JCP001
NCT
NCT02388906
Filter Clinical Trials by:
Biomarkers: